Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation

Published:2020-01 Issue:5 Volume:99 Page:e18811
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Liu Chunshui,Hu Ruiping,Du Zhonghua,Abecasis Manuel,Wang Cong

Funder

the Education Department of Jilin Province

the Natural Science Foundation of Jilin Province

the Health Foundation of Jilin Province

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference25 articles.

1. Myeloproliferative neoplasms: from origins to outcomes;Nangalia;Blood,2017

2. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms;Tefferi;Leukemia,2014

3. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2;Nangalia;N Engl J Med,2013

4. Somatic mutations of calreticulin in myeloproliferative neoplasms;Klampfl;N Engl J Med,2013

5. The co-occurrence of driver mutations in chronic myeloproliferative neoplasms;Boddu;Ann Hematol,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myeloproliferative neoplasms with concomitant CALR mutation and BCR::ABL1 translocation: diagnostic and therapeutic implications of a rare hybrid disease;Frontiers in Cell and Developmental Biology;2024-03-26

2. A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-04

3. Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology;Cells;2023-03-20

4. BCR::ABL1‐positive chronic myeloid leukaemia with CALR mutation;Clinical and Experimental Pharmacology and Physiology;2023-02-15

5. Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib;Clinical Case Reports;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3